Site icon OncologyTube

David Gilham on shRNA: Will This Affect Clinical Treatment? #ASCO2020 #ASCO

David Edward Gilham of The University of Manchester discusses single vector multiplexed shRNA provides a non-gene edited strategy to concurrently knockdown the expression of multiple genes in CAR T cells presented at this year’s virtual ASCO.

Read here: https://meetinglibrary.asco.org/record/189127/abstract

Exit mobile version